Other Assets, Current in USD of PLUS THERAPEUTICS, INC. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
PLUS THERAPEUTICS, INC. quarterly Other Assets, Current history and change rate from Q4 2010 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Other Assets, Current for the quarter ending 30 Sep 2025 was $985K, a 71% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $985K +$409K +71% 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $1.31M +$369K +39% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $1M +$12K +1.21% 31 Mar 2025 10-Q 30 May 2025
Q4 2024 $1.08M -$198K -15.5% 31 Dec 2024 10-Q 30 Oct 2025
Q3 2024 $576K +$89K +18.3% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $945K +$194K +25.8% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $989K +$83K +9.16% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $1.28M -$2.42M -65.4% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $487K -$53K -9.82% 30 Sep 2023 10-Q 31 Oct 2023
Q2 2023 $751K -$48K -6.01% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $906K +$41K +4.74% 31 Mar 2023 10-Q 20 Apr 2023
Q4 2022 $3.7M +$2.37M +179% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $540K -$277K -33.9% 30 Sep 2022 10-Q 20 Oct 2022
Q2 2022 $799K -$41K -4.88% 30 Jun 2022 10-Q 21 Jul 2022
Q1 2022 $865K -$134K -13.4% 31 Mar 2022 10-Q 21 Apr 2022
Q4 2021 $1.32M +$495K +59.7% 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 $817K -$99K -10.8% 30 Sep 2021 10-Q 21 Oct 2021
Q2 2021 $840K +$371K +79.1% 30 Jun 2021 10-Q 22 Jul 2021
Q1 2021 $999K +$448K +81.3% 31 Mar 2021 10-Q 22 Apr 2021
Q4 2020 $829K -$128K -13.4% 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 $916K +$414K +82.5% 30 Sep 2020 10-Q 22 Oct 2020
Q2 2020 $469K -$34K -6.76% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $551K -$185K -25.1% 31 Mar 2020 10-Q 14 May 2020
Q4 2019 $957K +$172K +21.9% 31 Dec 2019 10-K 22 Feb 2021
Q3 2019 $502K -$152K -23.2% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $503K -$334K -39.9% 30 Jun 2019 10-Q 15 Aug 2019
Q1 2019 $736K -$101K -12.1% 31 Mar 2019 8-K 10 Sep 2019
Q4 2018 $785K +$5K +0.64% 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 $654K -$238K -26.7% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $837K -$279K -25% 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 $837K +$337K +67.4% 31 Mar 2018 10-Q 11 May 2018
Q4 2017 $780K -$90K -10.3% 31 Dec 2017 8-K 10 Sep 2019
Q3 2017 $892K -$361K -28.8% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $1.12M -$147K -11.6% 30 Jun 2017 10-Q 11 Aug 2017
Q1 2017 $500K -$1.37M -73.2% 31 Mar 2017 10-Q 12 May 2017
Q4 2016 $870K -$685K -44.1% 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 $1.25M -$61K -4.64% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $1.26M +$277K +28.1% 30 Jun 2016 10-Q 05 Aug 2016
Q1 2016 $1.87M +$522K +38.8% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $1.56M +$563K +56.8% 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 $1.31M +$69K +5.54% 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 $986K -$302K -23.4% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 $1.34M -$47K -3.38% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $992K -$233K -19% 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 $1.25M +$117K +10.4% 30 Sep 2014 10-Q 07 Nov 2014
Q2 2014 $1.29M +$99K +8.33% 30 Jun 2014 10-Q 11 Aug 2014
Q1 2014 $1.39M +$202K +17% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $1.23M +$64K +5.51% 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 $1.13M +$38K +3.49% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $1.19M +$74K +6.64% 30 Jun 2013 10-Q 09 Aug 2013
Q1 2013 $1.19M +$54K +4.76% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 $1.16M +$324K +38.7% 31 Dec 2012 10-K 14 Mar 2014
Q3 2012 $1.09M +$388K +55.3% 30 Sep 2012 10-Q 09 Nov 2012
Q2 2012 $1.12M +$266K +31.3% 30 Jun 2012 10-Q 09 Aug 2012
Q1 2012 $1.14M 31 Mar 2012 10-Q 10 May 2012
Q4 2011 $837K +$3K +0.36% 31 Dec 2011 10-K 15 Mar 2013
Q3 2011 $702K 30 Sep 2011 10-Q 08 Nov 2011
Q2 2011 $849K 30 Jun 2011 10-Q 09 Aug 2011
Q4 2010 $834K 31 Dec 2010 10-K/A 07 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.